Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients. 2014

Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
Mansoura University, Oncology Center, Faculty of Medicine, Mansoura, Egypt. Electronic address: tawragab2005@yahoo.com.

BACKGROUND Breast cancer in Egypt is the most common cancer among women and is the leading cause of cancer mortality. Traditionally, axillary lymph node involvement is considered among the most important prognostic factors in breast cancer. Nonetheless, accumulating evidence suggests that axillary lymph node ratio should be considered as an alternative to classical pN classification. METHODS We performed a retrospective analysis of patients with operable node-positive breast cancer, to investigate the prognostic significance of axillary lymph node ratio. RESULTS Five-hundred patients were considered eligible for the analysis. Median follow-up was 35 months (95% CI 32-37 months), the median disease-free survival (DFS) was 49 months (95% CI, 46.4-52.2 months). The classification of patients based on pN staging system failed to prognosticate DFS in the multivariate analysis. Conversely, grade 3 tumors, and the intermediate (>0.20 to ≤0.65) and high (>0.65) LNR were the only variables that were independently associated with adverse DFS. The overall survival (OS) in this series was 69 months (95% CI 60-77). CONCLUSIONS The analysis of outcome of patients with early breast cancer in Egypt identified the adverse prognostic effects of high tumor grade, ER negativity and intermediate and high LNR on DFS. If the utility of the LNR is validated in other studies, it may replace the use of absolute number of axillary lymph nodes.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004534 Egypt A country in northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip, and the Red Sea north of Sudan, and includes the Asian Sinai Peninsula Its capital is Cairo. Arab Republic of Egypt,United Arab Republic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001365 Axilla Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm. Armpit,Underarm

Related Publications

Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
June 2010, Asia-Pacific journal of clinical oncology,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
November 2006, Gut,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
January 2015, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
March 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
October 2015, American journal of surgery,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
September 2011, Journal of breast cancer,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
January 2015, SpringerPlus,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
January 2013, PloS one,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
July 2018, Medicine,
Tawfik R Elkhodary, and Mohamed A Ebrahim, and Elsayed E Hatata, and Nermeen A Niazy
January 2019, Indian journal of pathology & microbiology,
Copied contents to your clipboard!